Risperdal Male Breast Lawsuits

Risperdal is a prescription antipsychotic that has been linked to abnormal breast growth in boys and men. Gynecomastia is a medical condition which can cause significant emotional trauma. Boys and men who developed male breasts while taking Risperdal have filed lawsuits nationwide against Janssen and Johnsons & Johnson, saying they were not adequately warned of the drug's risks. Johnson & Johnson resolved a federal lawsuit in 2013 when it agreed to pay $2.2 billion to the Department of Justice over allegations of fraud, the payment of kickbacks to physicians who prescribed Risperdal for uses that had not been FDA approved, and downplaying the Risperdal gynecomastia risk on the drug's label.

• Risperdal Gynecomastia
• FDA Risperdal Gynecomastia Warning
• Risperdal Male Breast Lawsuits
• Risperdal Lawsuit FAQ

Risperdal Male Breast Risk

Risperdal (risperidone) is a drug commonly used in the United States to treat schizophrenia, Bipolar I Disorder, and autism. The drug treats these conditions by altering hormone levels in the body, which regulate traits commonly associate with one gender or the other. Risperdal works by raising the body's prolactin level, the hormone responsible for boosting the growth of breast tissue. Teenage boys and men who have taken Risperdal report developing large male breasts which must be surgically removed in some cases. There are no serious physical complications related to the growth of breast tissue in men and boys, but there are obvious psychological and emotional implications. In the face of Risperdal lawsuit allegations, Janssen officials have asserted that male breast growth is harmless. Teenage boys and men who have grown breasts as a result of Risperdal widely disagree, as do psychologists and other experts.

Risperdal Gynecomastia

Risperdal is an anti-psychotic drug used to treat irritability related to austism as well as schizophrenia and Bipolar I disorder in children and adults. It is sold by Janssen, a subsidiary of Johnson & Johnson, and has been in use in the United States since 1993. The drug works by altering the body's natural hormone levels. While affective at treating the conditions for which it is approved, Risperdal has been found to cause abnormal swelling of breast tissue and even lactation in men and boys. Male breast growth can cause emotional trauma, social stigma, and mental anguish.

Multiple research teams have produced evidence linking Risperdal to heightened prolactin levels and abnormal male breast growth. An article in the Wall Street Journal quoted Dr. P. Murali Doraiswamy, the Duke psychiatrist who co-authored an FDA study on prolactin and antipsychotics as saying that Risperdal has been linked to a higher risk of male breast growth than any similar drug. This is just one of several pieces of medical research linking Risperdal to unwanted breast growth. Risperdal gynecomastia lawsuits assert the company knew of the risk of breast growth yet downplayed it in drug advertising in order to increase sales. In 2007, Risperdal reached record sales of $4.5 billion. Research shows that the rate at which males taking Risperdal experience breast growth is far higher than the 2.3% Janssen projected based on clinical testing.

FDA Risperdal Male Breast Warning

Federal regulators have never issued an official warning regarding the risk of male breasts from Risperdal. This fact, in tandem with the drug maker's failure to issue a clear warning about the risk, has resulted in significant damage, say some experts. A warning issued by federal regulators brings the public's attention to a medical condition, and makes physicians take note of existing research. With no FDA warning on Risperdal breast growth, boys and men have taken the drug without knowledge of the threat. And when they do develop breast tissue, they are slower to come forward if they do not know the risk is widespread. Suffering their shame alone, men and boys who have grown breasts from Risperdal encounter significant mental anguish, according to psychologists.

Risperdal Lawsuits

Boys and men who have developed breasts while taking Risperdal may seek compensation for the medical expenses, damages, and mental anguish they have suffered as a result of the drug by filing a Risperdal lawsuit against Janssen and Johnson & Johnson. Risperdal lawsuits aim to hold the drug company accountable for its failure to adequately warn consumers of the known risks of Risperdal. Men and boys who have been harmed by Risperdal breast growth may be entitled to compensation as a result of the suffering, damages, and expenses they have sustained.

No Fees Unless We Collect for You - Contingency Representation for Risperdal Gynecomastia Lawsuits

Attorneys handling Risperdal lawsuits are now accepting claims from boys, men, and the family members of males who have developed breasts while taking Risperdal. These individuals may be entitled to compensation for the damages, expenses and emotional anguish they have suffered as a result of taking Risperdal. The Onder Law Firm will represent all persons involved in a Risperdal male breast lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please complete the brief online contact form or call us at 1-800-799-2824 and one of our attorneys handling national* Risperdal lawsuits will contact you to answer any of your questions.

Risperdal Lawsuit FAQ

Who qualifies to file a Risperdal gynecomastia lawsuit?

Persons and the family members of persons who developed male breasts while taking Risperdal may have legal grounds to file a Risperdal male breast lawsuit against the drug maker Johnson & Johnson and its subsidiary Janssen.

What has research revealed about Risperdal and male breasts?

Multiple research studies have shown that the rate of male breast development in males taking Risperdal is much higher than early testing projected. In fact, researchers say that the majority of cases of male breast growth from this type of anti-psychotic drug stem from Risperdal.

When did researchers first learn about the Risperdal male breast development risk?

The potential for breast growth in males is possible with any drug in Risperdal's class, so the risk of male breast development has always been known. Researchers now believe that breast growth is far more common among men and boys taking Risperdal than the drug company projected. Risperdal lawsuits accuse Janssen and Johnson & Johnson of failing to clearly warn consumers of the risk.

What is the fee to have my case reviewed?

Our attorneys will always listen to your situation and give their analysis of your case absolutely free of charge.

How much will it cost to file a Risperdal lawsuit?

These Risperdal breast growth attorneys work on a contingency basis, meaning there is no charge unless they win compensation on your behalf.